Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 03, 2024

Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer

JAMA Network Open

 

Additional Info

JAMA Network Open
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer
JAMA Netw Open 2024 Oct 01;7(10)e2437871, A Goldkorn, C Tangen, M Plets, D Bsteh, T Xu, JK Pinski, S Ingles, TJ Triche, GR MacVicar, DA Vaena, AW Crispino, DJ McConkey, PN Lara, MHA Hussain, DI Quinn, TB Dorff, SP Lerner, I Thompson, N Agarwal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading